ArticleThe British journal of ophthalmology2012

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

Rob J Van Geest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.